Skip to content

Acute impairment of renal function in COVID-19: study on incidence, risk factors and mortality

Acute Kidney Injury in Infectious Coronavirus Disease: a study on incidence, risk factors and mortality

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-62y3h7
Enrollment
Unknown
Registered
2020-05-18
Start date
2020-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute renal failure

Interventions

One group of 1000 patients will be submitted a clinical evaluation of data collected obtained through patient consultation and medical records consecutively of all hospitalized patients diagnosed with
Other

Sponsors

Faculdade de Medicina de Botucatu
Lead Sponsor
Faculdade de Medicina de Botucatu
Collaborator
Departamento de Clínica Médica da Faculdade de Medicina de Botucatu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: suspected diagnosis of COVID-19

Exclusion criteria

Exclusion criteria: negative test for COVID-19; patients without diuresis control or at least two creatinine tests during hospitalization; pregnant women; age under 18; patients with advanced CKD (Cl Cr <30 ml / min; kidney transplant patients.

Design outcomes

Primary

MeasureTime frame
Assess the presence of acute kidney injury. The results will be presented using descriptive statistics of the studied population and the occurrence of AKI will be established as a dependent variable, using the Chi-Square Test for the statistical significance between this variable and the categorical variables and the t Test for this variable and the variables continuous. Afterwards, multivariate analysis will be performed, through the construction of a logistic regression model, with Odds Ratio (OR) calculations, including all independent variables that showed an association with the outcome, with p under 0.20. A similar procedure will be performed from the establishment, as a dependent variable, the occurrence of death. All results of the hypothesis tests will be discussed at the 5% significance level (p under 0.05)

Secondary

MeasureTime frame
Discharge or death ;Length of ICU and hospital stay

Countries

Brazil

Contacts

Public ContactWelder Zamoner

Departamento de Clínica Médica da Faculdade de Medicina de Botucatu

welderzamoner@gmail.com55-11-997636310

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026